Newsroom

December 3, 2024
December 3, 2024

Training Begins for New ULTRAOX Systems in the Republic of Congo

Training for ULTRAOX systems has started in the Republic of Congo, equipping healthcare professionals with the skills to provide reliable medical-grade oxygen. Together, we’re making DRC better and bringing healthcare closer to all.
Training Begins for New ULTRAOX Systems in the Republic of Congo

Today marks a significant milestone as training begins for the new ULTRAOX systems in the Republic of Congo. This comprehensive program is designed to equip local healthcare professionals with the skills and knowledge needed to operate and maintain these advanced oxygen systems, ensuring a stable supply of medical-grade oxygen to hospitals and clinics across the region.

Training for ULTRAOX systems has started in the Republic of Congo, equipping healthcare professionals with the skills to provide reliable medical-grade oxygen. Together, we’re making DRC better and bringing healthcare closer to all.

Empowering Local Healthcare

This initiative goes beyond delivering technology—it’s about empowering communities. By training healthcare professionals to master these systems, we’re creating a self-sustaining solution that ensures reliable oxygen access for critical care. This step is vital in improving patient outcomes and enhancing healthcare infrastructure in the Republic of Congo.

Closer to Our Vision

At Ultra Controlo, our vision is to revolutionize healthcare by making it accessible and efficient for everyone, no matter where they are. This training program represents a tangible step toward that goal, helping to make the Democratic Republic of Congo better equipped to meet the growing demands of modern healthcare.

A Heartfelt Thanks

We extend our sincere gratitude to our team on the ground and our local partners who are dedicated to making this vision a reality. Together, we are driving meaningful change and building a brighter, healthier future.

Resources

Newsletter

Get our news directly
to your mailbox.

Thank you for joining us! 🎉
Oops! Seems like you have a typo.
By clicking the subscribe button you're agreeing with our following Terms and Conditions